Synlogic, Inc. Files 8-K on Security Holder Votes and Exhibits

TL;DR

SYBX filed an 8-K for security holder votes & financials.

AI Summary

On December 4, 2024, Synlogic, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The company, formerly known as Mirna Therapeutics, Inc., is incorporated in Delaware and is involved in the Pharmaceutical Preparations industry.

Why It Matters

This filing indicates important corporate actions and financial reporting by Synlogic, Inc., which could impact investors' understanding of the company's governance and financial health.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant financial distress or operational changes.

Key Numbers

• 001-37566 — SEC File Number (Identifies the company's filing with the SEC.)
• 26-1824804 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• SYNLOGIC, INC. (company) — Registrant
• Mirna Therapeutics, Inc. (company) — Former company name
• 20241204 (date) — Date of earliest event reported
• 20241205 (date) — Filing date
• 001-37566 (company) — SEC File Number
• 26-1824804 (company) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share SYBX The NASDAQ Capital M

Filing Documents

• sybx-20241204.htm (8-K) — 65KB
• 0000950170-24-133381.txt ( ) — 186KB
• sybx-20241204.xsd (EX-101.SCH) — 32KB
• sybx-20241204_htm.xml (XML) — 4KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. (a) On December 4, 2024, the Company held its Annual Meeting. At the Annual Meeting, a quorum of 9,633,925 shares of the Company's common stock, or 82.36% of the outstanding shares of common stock entitled to vote as of the record date of November 1, 2024, were present or represented by proxy. (b) The following actions were taken at the Annual Meeting: 1. The following nominee was reelected to serve on the Company's board of directors (the "Board of Directors") as Class III director until the Company's 2027 annual meeting of stockholders, based on the following votes: Nominee Shares Voted For Shares Voted To Withhold Authority Broker Non-Vote Nick Leschly 6,876,144 317,492 2,440,289 After the Annual Meeting, Richard P. Shea and James Flynn continued to serve as Class I Directors for terms that expire at the 2025 annual meeting, and Peter Barrett, Ph.D., Michael Heffernan, and Edward Mathers continued to serve as Class II Directors for terms that expire at the 2026 annual meeting. 2. The Company's stockholders approved, in a non-binding advisory vote, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, based on the following votes: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Votes 3,337,618 543,326 3,312,692 2,440,289 3. The selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified, based on the following votes: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Votes 9,589,958 43,758 209 — I tem 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: December 4, 2024 Synlogic, Inc. By: /s/ Antoine Awad Name: Title: Antoine Awad Principal Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR